PP
SPPI

Paloma Partners’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Paloma Partners’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-51,535
Closed -$174K – 2586
2020
Q2 		$174K Buy
+51,535
New +$150K ﹤0.01% 1747
2019
Q2 		– Sell
-14,990
Closed -$160K – 2281
2019
Q1 		$160K Buy
+14,990
New +$161K ﹤0.01% 1549
2017
Q1 		– Sell
-20,009
Closed -$89K – 2310
2016
Q4 		$89K Buy
+20,009
New +$83.9K ﹤0.01% 1911
2015
Q1 		– Sell
-15,500
Closed -$107K – 1482
2014
Q4 		$107K Buy
+15,500
New +$114K ﹤0.01% 1061

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Paloma Partners's SPPI Position: Q3 2020 in Review

Paloma Partners sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2020, closing a stake of 51,535 shares — an estimated $174K sold.

Paloma Partners first reported a position in SPPI in Q4 2014 and held it in 4 quarters. The position peaked at $174K in Q2 2020. 159 funds tracked by Wall St. Rank hold SPPI as of Q3 2020.

  • Paloma Partners reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • Paloma Partners sold 51,535 Spectrum Pharmaceuticals Inc shares in Q3 2020, an estimated $174K.
  • Paloma Partners first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 4 quarters.
  • Paloma Partners's Spectrum Pharmaceuticals Inc position peaked at $174K in Q2 2020.
  • 159 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2020.

Based on Paloma Partners's 13F filing for Q3 2020, filed 16 Nov 2020.